BLRM-EffTox:一个无的两阶段第1阶段贝叶斯逻辑回归设计,包含有效性-毒性权衡,以优化剂量
Xin Liu1, Cynthia Basu2, Arnab Kumar Maity3
1Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH, USA.
Journal of biopharmaceutical statistics
|February 23, 2026
概括
这项研究引入了BLRM-EffTox,这是一个新的1期瘤学试验设计,它平衡了疗效和毒性,以找到最佳剂量. 它通过选择多个剂量来更好地选择治疗方法,优于传统方法.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 瘤学 药物开发 药物开发
背景情况:
- 传统的1期瘤学试验侧重于使用剂量限制毒性 (DLT) 的最大耐受剂量 (MTD).
- 新型癌症疗法可能不遵循剂量-疗效关系,需要在疗效和毒性之间保持平衡.
- 美国食品和药物管理局的Project Optimus倡议强调了剂量优化的必要性.
研究的目的:
- 提出一种新的无双阶段第一阶段试验设计,BLRM-EffTox,通过考虑疗效和毒性来优化剂量选择.
- 扩展贝叶斯逻辑回归模型 (BLRM) 以共同建模毒性和疗效事件.
- 通过在扩张阶段的患者进行适应性随机选择来确定最佳剂量.
主要方法:
- 开发了一个两阶段无第一阶段设计 (BLRM-EffTox) 集成贝叶斯逻辑回归.
- 引入了一种新的"决策指数",用于在第一阶段选择多个剂量.
- 使用模拟,比较了BLRM-EffTox与基准设计 (BLRM-MTD,BLRM-Eff2d).
主要成果:
- 模拟表明,BLRM-EffTox设计在选择最佳剂量方面表现优于基准设计.
- 拟议的设计有效地平衡了新瘤治疗的疗效和毒性.
- 该研究为早期瘤学试验中的适应剂量选择提供了一个框架.
结论:
- BLRM-EffTox为1期瘤学试验设计提供了一种改进的方法,超越MTD以优化剂量选择.
- 该设计特别适用于新型癌症疗法,其中剂量-疗效关系复杂.
- 案例研究说明了BLRM-EffTox在现实临床环境中的实际应用.
更多相关视频
相关概念视频
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
284
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
284
Dosage Regimens: Designs and Approaches
386
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
386
Bioavailability Study Design: Single Versus Multiple Dose Studies
283
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
283
Dosage Regimens: Partial Pharmacokinetic Parameters
225
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
225
Dosage Regimen Designs: Nomograms and Tabulations
261
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
261
Dose Response Curve: Conventional Versus Nonmonotonic
72
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response...
72


